Limpid Markets
← Back to Intelligence

Oruka Therapeutics stock surges on positive psoriasis trial data

Investing.com Gold Tier 2 2026-04-27 11:10 UTC 📖 1 min read Neutral

Investing.com Gold reports: Oruka Therapeutics stock surges on positive psoriasis trial data. Full body text was unavailable at ingest time, so this brief is based on headline context.

↗ Read Original